276 related articles for article (PubMed ID: 35448283)
21. A review on electronic nose for diagnosis and monitoring treatment response in lung cancer.
Vadala R; Pattnaik B; Bangaru S; Rai D; Tak J; Kashyap S; Verma U; Yadav G; Dhaliwal RS; Mittal S; Hadda V; Madan K; Guleria R; Agrawal A; Mohan A
J Breath Res; 2023 Mar; 17(2):. PubMed ID: 36720157
[TBL] [Abstract][Full Text] [Related]
22. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
[TBL] [Abstract][Full Text] [Related]
23. Exhaled VOC detection in lung cancer screening: a comprehensive meta-analysis.
Fan X; Zhong R; Liang H; Zhong Q; Huang H; He J; Chen Y; Wang Z; Xie S; Jiang Y; Lin Y; Chen S; Liang W; He J
BMC Cancer; 2024 Jun; 24(1):775. PubMed ID: 38937687
[TBL] [Abstract][Full Text] [Related]
24. Exhaled breath analysis for lung cancer.
Dent AG; Sutedja TG; Zimmerman PV
J Thorac Dis; 2013 Oct; 5 Suppl 5(Suppl 5):S540-50. PubMed ID: 24163746
[TBL] [Abstract][Full Text] [Related]
25. Clinical Application of Exhaled Breath Condensate in Diagnosis of Diseases.
Zhao Z; Meng W
Discov Med; 2024 Jun; 36(185):1154-1161. PubMed ID: 38926101
[TBL] [Abstract][Full Text] [Related]
26. Assessment, origin, and implementation of breath volatile cancer markers.
Haick H; Broza YY; Mochalski P; Ruzsanyi V; Amann A
Chem Soc Rev; 2014 Mar; 43(5):1423-49. PubMed ID: 24305596
[TBL] [Abstract][Full Text] [Related]
27. A review of exhaled breath: a key role in lung cancer diagnosis.
Marzorati D; Mainardi L; Sedda G; Gasparri R; Spaggiari L; Cerveri P
J Breath Res; 2019 Apr; 13(3):034001. PubMed ID: 30754033
[TBL] [Abstract][Full Text] [Related]
28. Breath carbonyl compounds as biomarkers of lung cancer.
Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA
Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567
[TBL] [Abstract][Full Text] [Related]
29. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
[TBL] [Abstract][Full Text] [Related]
30. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis.
Chen X; Xu F; Wang Y; Pan Y; Lu D; Wang P; Ying K; Chen E; Zhang W
Cancer; 2007 Aug; 110(4):835-44. PubMed ID: 17599760
[TBL] [Abstract][Full Text] [Related]
31. Exhaled breath biopsy: a new cancer detection paradigm.
Abderrahman B
Future Oncol; 2019 May; 15(15):1679-1682. PubMed ID: 30977676
[No Abstract] [Full Text] [Related]
32. Exhaled breath analysis in patients with potentially curative lung cancer undergoing surgery: a longitudinal study.
Herth J; Schmidt F; Basler S; Sievi NA; Kohler M
J Breath Res; 2024 May; 18(3):. PubMed ID: 38718786
[TBL] [Abstract][Full Text] [Related]
33. Exhaled Breath Analysis for Diabetes Diagnosis and Monitoring: Relevance, Challenges and Possibilities.
Dixit K; Fardindoost S; Ravishankara A; Tasnim N; Hoorfar M
Biosensors (Basel); 2021 Nov; 11(12):. PubMed ID: 34940233
[TBL] [Abstract][Full Text] [Related]
34. High performance exhaled breath biomarkers for diagnosis of lung cancer and potential biomarkers for classification of lung cancer.
Long Y; Wang C; Wang T; Li W; Dai W; Xie S; Tian Y; Liu M; Liu Y; Peng X; Liu Y; Zhang Y; Wang R; Li Q; Duan Y
J Breath Res; 2021 Feb; 15(1):016017. PubMed ID: 33586667
[TBL] [Abstract][Full Text] [Related]
35. VOC breath biomarkers in lung cancer.
Saalberg Y; Wolff M
Clin Chim Acta; 2016 Aug; 459():5-9. PubMed ID: 27221203
[TBL] [Abstract][Full Text] [Related]
36. Clinical contributions of exhaled volatile organic compounds in the diagnosis of lung cancer.
Oguma T; Nagaoka T; Kurahashi M; Kobayashi N; Yamamori S; Tsuji C; Takiguchi H; Niimi K; Tomomatsu H; Tomomatsu K; Hayama N; Aoki T; Urano T; Magatani K; Takeda S; Abe T; Asano K
PLoS One; 2017; 12(4):e0174802. PubMed ID: 28384298
[TBL] [Abstract][Full Text] [Related]
37. Sex and Smoking Status Effects on the Early Detection of Early Lung Cancer in High-Risk Smokers Using an Electronic Nose.
McWilliams A; Beigi P; Srinidhi A; Lam S; MacAulay CE
IEEE Trans Biomed Eng; 2015 Aug; 62(8):2044-54. PubMed ID: 25775482
[TBL] [Abstract][Full Text] [Related]
38. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting.
Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D
Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557
[TBL] [Abstract][Full Text] [Related]
39. The analysis of volatile organic compounds in exhaled breath and biomarkers in exhaled breath condensate in children - clinical tools or scientific toys?
van Mastrigt E; de Jongste JC; Pijnenburg MW
Clin Exp Allergy; 2015 Jul; 45(7):1170-88. PubMed ID: 25394891
[TBL] [Abstract][Full Text] [Related]
40. Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review.
Oakley-Girvan I; Davis SW
Cancer Biomark; 2017 Dec; 21(1):29-39. PubMed ID: 29060925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
